EUVIMEDEUVIMED entdecken
Open Access

Amphotericin B Deoxycholate Treatment of Post–Kala-Azar Dermal Leishmaniasis in India

Shyam Sundar, Jaya Chakravarty, Jitendra Singh, Deepak Verma, Neha Agrawal, Anju Dinkar

The American Journal of Tropical Medicine and Hygiene · 2024

DOI: 10.4269/ajtmh.23-0738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Shyam Sundar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Hauptthemen laut MEDLINE: Amphotericin B, Leishmaniasis, Visceral, Antiprotozoal Agents, Deoxycholic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post–kala-azar dermal leishmaniasis (PKDL) is widely prevalent in the endemic regions of India, but its treatment remains unsatisfactory. The WHO recommends a 12-week treatment with oral miltefosine, but its ocular toxicities are a serious concern. The late 1980s and early 1990s saw the use of sodium stibogluconate and amphotericin B (AmB) for a brief period. Both drugs had frequent adverse events and were expensive, and the duration of treatments was unacceptably long. This retrospective study evaluated, analyzed, and reported the outcomes of PKDL patients treated with a shorter course of AmB, the most effective antileishmanial drug. The hospital records of PKDL patients treated with AmB by 30 alternate-day infusions over 60 days (instead of conventional 60–80 infusions over 100–120 days) between September 2010 and August 2016 were reviewed. Only patients with confirmed parasitological diagnosis were included. Their records were studied for treatment-related adverse events, end-of-treatment parasitological status, and 12-month follow-up results. One hundred two patients were eligible for this study between September 2010 and August 2016. After therapy, 92/102 (90.2%) patients improved; 3 (2.9%) had to cease treatment owing to severe adverse effects, and one died of severe diarrhea unrelated to AmB. Six (5.9%) patients withdrew consent before the treatment was complete. At the 12-month evaluation, 89/102 (87.3%) patients attained a final cure. A 30-infusion regimen of AmB remains highly effective in PKDL. Without a shorter, safer, and more economical regimen for the treatment of PKDL, it should be used until a better regimen is available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphotericin BLeishmaniasis, VisceralAntiprotozoal AgentsDeoxycholic AcidLeishmaniasis, CutaneousDrug CombinationsHumansMaleIndiaFemaleAdultRetrospective StudiesMiddle AgedAdolescentYoung AdultChildTreatment OutcomeAged

Substanzen

Amphotericin BAntiprotozoal AgentsDeoxycholic Acidamphotericin B, deoxycholate drug combinationDrug Combinations

Autor:innen und Institutionen

  • Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
  • Kala-Azar Medical Research Center, Muzaffarpur, India.
  • Department of Medicine, University of Florida, Jacksonville, Florida.
  • Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
  • Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Zitieren

APA

Sundar, S., Chakravarty, J., Singh, J., Verma, D., Agrawal, N., & Dinkar, A. (2024). Amphotericin B Deoxycholate Treatment of Post–Kala-Azar Dermal Leishmaniasis in India. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0738

Vancouver

Sundar S, Chakravarty J, Singh J, Verma D, Agrawal N, Dinkar A. Amphotericin B Deoxycholate Treatment of Post–Kala-Azar Dermal Leishmaniasis in India. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0738

BibTeX
@article{Sundar2024,
  author = {Sundar, Shyam and Chakravarty, Jaya and Singh, Jitendra and Verma, Deepak and Agrawal, Neha and Dinkar, Anju},
  title = {Amphotericin B Deoxycholate Treatment of Post–Kala-Azar Dermal Leishmaniasis in India},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2024},
  doi = {10.4269/ajtmh.23-0738}
}
Kostenlos starten →